Researchers discover method to enhance engineered T-cell cancer therapies

Researchers at UCLA Health Jonsson Comprehensive Cancer Center have found a new strategy to strengthen and potentially extend the lifespan of engineered T-cells used in cancer immunotherapy. This discovery could improve the effectiveness of treatments that utilize a patient's own immune cells to combat cancer.

Originally published by gnews